AE-IPF has a dismal prognosis and current treatment consists mainly of supportive care and symptom palliation. There is a lack of consensus on current therapies for AE-IPF, including corticosteroids, but current randomized control studies for newer therapeutic strategies may hold promise.
Keyphrases
- idiopathic pulmonary fibrosis
- interstitial lung disease
- healthcare
- chronic obstructive pulmonary disease
- double blind
- respiratory failure
- liver failure
- open label
- clinical trial
- machine learning
- clinical practice
- chronic pain
- phase ii
- combination therapy
- affordable care act
- pain management
- patient reported
- deep learning
- mechanical ventilation